| Product Code: ETC8197917 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Malta continues to rely on imports for non-injectable insulin, with significant shipments arriving from key exporting countries such as India, Israel, Ireland, Germany, and Belgium in 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the impressive Compound Annual Growth Rate (CAGR) of 10.1% from 2020 to 2024 highlights sustained growth in the sector. The remarkable growth rate of 29.61% from 2023 to 2024 signals a surge in demand for non-injectable insulin in Malta, reflecting a positive outlook for the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Non-Injectable Insulin Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Non-Injectable Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Non-Injectable Insulin Market - Industry Life Cycle |
3.4 Malta Non-Injectable Insulin Market - Porter's Five Forces |
3.5 Malta Non-Injectable Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Malta Non-Injectable Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malta Non-Injectable Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Malta |
4.2.2 Growing awareness about the benefits of non-injectable insulin |
4.2.3 Technological advancements in non-injectable insulin delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of non-injectable insulin products |
4.3.2 Limited reimbursement policies for non-injectable insulin in healthcare systems |
5 Malta Non-Injectable Insulin Market Trends |
6 Malta Non-Injectable Insulin Market, By Types |
6.1 Malta Non-Injectable Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malta Non-Injectable Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Malta Non-Injectable Insulin Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 Malta Non-Injectable Insulin Market Revenues & Volume, By Sprays, 2021- 2031F |
6.1.5 Malta Non-Injectable Insulin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Malta Non-Injectable Insulin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Malta Non-Injectable Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Malta Non-Injectable Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
6.2.4 Malta Non-Injectable Insulin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
7 Malta Non-Injectable Insulin Market Import-Export Trade Statistics |
7.1 Malta Non-Injectable Insulin Market Export to Major Countries |
7.2 Malta Non-Injectable Insulin Market Imports from Major Countries |
8 Malta Non-Injectable Insulin Market Key Performance Indicators |
8.1 Patient adherence rate to non-injectable insulin therapy |
8.2 Percentage of healthcare professionals recommending non-injectable insulin |
8.3 Number of research studies on the efficacy and safety of non-injectable insulin |
9 Malta Non-Injectable Insulin Market - Opportunity Assessment |
9.1 Malta Non-Injectable Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Malta Non-Injectable Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malta Non-Injectable Insulin Market - Competitive Landscape |
10.1 Malta Non-Injectable Insulin Market Revenue Share, By Companies, 2024 |
10.2 Malta Non-Injectable Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |